Structured Summary
Abstract
A pharmaceutical preparation of sitagliptin phosphate and metformin hydrochloride that is used in the treatment of TYPE 2 DIABETES.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
Synonyms
4 entry terms
- Sitagliptin Phosphate Metformin Hydrochloride Drug Combination
- Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination
- Sitagliptin Phosphate-Metformin Hydrochloride Drug Combination
- Janumet
MeSH Record
Aspects Covered
24 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, antagonists & inhibitors, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
2016 (2008)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Metformin Hydrochloride Drug Combination Sitagliptin Phosphate. Medical Subject Headings (MeSH). 2026. Unique ID D000068899. http://id.nlm.nih.gov/mesh/2026/D000068899
- Metformin Hydrochloride Drug Combination Sitagliptin Phosphate. In: Wikipedia. https://en.wikipedia.org/wiki/Sitagliptin/metformin
- Metformin Hydrochloride Drug Combination Sitagliptin Phosphate. In: Wikidata. https://www.wikidata.org/wiki/Q7531599